Daniel Kahneman, the ‘godfather’ of behavioural economics, has been challenged by rival psychologist Gerd Gigerenzer, director of the Centre for Cognition and Adaptive Behaviour at the Max Planck institute in Berlin, who claims that Kahneman presents ‘an unfairly negative view of the human mind’.
Gigerenzer’s book Risk Savvy: How to Make Good Decisions debunks the behavioural economics of Daniel Kahneman, and Cass Sunstein and Richard Thaler, authors of the bestselling book “Nudge”, who, along with the authors of Freakonomics, were once David Cameron’s pet thinkers.
Tim Adams reports on it all in the Observer.
“In an increasingly complex and specialised world, Gigerenzer preaches a gospel of greater simplicity. He suggests that the outcome of decisions of any complexity – a complexity of, say, trying to organise a successful picnic or greater – are impossible to accurately predict with any mathematical rational model, and therefore more usefully approached with a mixture of gut instinct and what he calls heuristics, the learned rules of thumb of any given situation. He believes, and he has some evidence to prove it, that such judgments prove sounder in practice than those based purely on probability.” […]
“Though Kahneman himself carefully limits its potential political application, his argument that we are irretrievably in thrall to our fallacies, in Gigernzer’s view, only strengthens the argument for such paternalism from government. Nudge theory becomes the more palatable expression of a deliberate wider manipulation. It makes us weaker and less questioning citizens.
Gigerenzer proposes an alternative solution. He believes, with education, the teaching of critical thinking about statistical probability, people can become more usefully ‘risk savvy'”
– Videos of Gerd Gigerenzer at TEDxZurich (2013) and TEDxNorrköping (2012)
– “Risk Savvy” book reviews in The Financial Times | The Economist | Times Higher Education
– An older, but in-depth review on the debate by Nick Dunbar
We are an international experience design consultancy helping companies and organisations to innovate their products, services and processes by putting people and their experiences first.
Vaccine hesitancy is a top10 global health threat. Dealing with it successfully requires understanding it as a behaviour and generating a holistic view of people’s perspectives & ecosystems. This way we can identify the best opportunities for intervention. Here is Experientia’s position on vaccine hesitancy and our tailor-made support for the vaccine industry.
100&Change is a MacArthur Foundation competition for a $100 million grant to fund a single proposal that will make measurable progress toward solving a significant problem. 100&Change will select a bold proposal that promises real progress toward solving a critical problem of our time. And it will award a $100 million grant to help make […]
Then we are interested in hearing from you. We have several positions available for talented UX/UI and service designers who are passionate about creating world-class user experiences. Please see the job descriptions on our website for more information, and send us your CV with a cover letter statement about yourself, your experience, and what UX […]
Experientia is proud to have been a key participant at the Roche Innovation Summit, held at Roche headquarters in Basel Switzerland on 19 June 2018. Themed “Transforming the Healthcare Experience Together”, the summit aimed to galvanize the Roche community around the future transformation of healthcare and diagnostics. With 800 attendees from Roche and Genentech global […]
Hai una startup? Hai mai pensato ai benefici che potrebbe trarre dal Design Thinking? Questa è l’opportunità per scoprirlo! DesAlps Workshop #2: Il Design Thinking per la tua startup! Giovedì 28 giugno 2018 – dalle 9:30 alle 17:00 @ I3P | Corso Castelfidardo 30/a, Torino —– Nell’ambito del progetto europeo DesAlps, un team di esperti […]